-+ 0.00%
-+ 0.00%
-+ 0.00%

Yasheng Pharmaceutical (06855): The trustee purchased 50,000 shares for the purpose of the 2022 restricted share unit plan

智通财经·09/28/2026 14:41:08
语音播报

According to Zhitong Finance App, Yasheng Pharmaceutical (06855) issued an announcement. On September 28, 2026, the trustee announced that the 2022 restricted share unit plan aims to purchase a total of 50,000 existing shares on the market to satisfy the restricted share units after ownership.